Jan Beyer-Westendorf Selected Research

Therapeutics

5/2024	Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.
4/2024	Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline.
4/2024	Management of Deep Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline.
1/2024	Risk Profiles and Treatment Patterns in Atrial Fibrillation Patients with Chronic Kidney Disease Receiving or not Receiving Anticoagulation Therapy.
11/2023	Cancer-Associated Venous Thromboembolism-Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline.
11/2023	Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial.
10/2022	Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry.
8/2022	Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study.
5/2022	Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry.
1/2022	Effectiveness and safety of edoxaban therapy in daily-care patients with atrial fibrillation. Results from the DRESDEN NOAC REGISTRY.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan Beyer-Westendorf Research Topics

Disease

91	Hemorrhage 05/2024 - 01/2012
67	Venous Thromboembolism 04/2024 - 01/2012
30	Atrial Fibrillation 05/2024 - 08/2014
24	Neoplasms (Cancer) 11/2023 - 04/2010
22	Stroke (Strokes) 05/2024 - 04/2014
22	Thrombosis (Thrombus) 01/2023 - 10/2013
19	Venous Thrombosis (Deep-Vein Thrombosis) 04/2024 - 10/2011
17	Pulmonary Embolism 04/2024 - 01/2012
9	Thrombocytopenia (Thrombopenia) 04/2024 - 02/2014
7	Embolism (Embolus) 02/2024 - 01/2016
5	Ischemic Stroke 05/2024 - 02/2016
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023 - 01/2019
4	Cerebral Hemorrhage 05/2024 - 01/2020
4	COVID-19 11/2023 - 01/2021
4	Wounds and Injuries (Trauma) 05/2022 - 02/2015
4	Menorrhagia 05/2021 - 01/2016
3	Critical Illness (Critically Ill) 10/2023 - 11/2018
3	Body Weight (Weight, Body) 01/2019 - 09/2016
3	Uterine Hemorrhage (Uterine Bleeding) 10/2016 - 01/2016
2	Hematoma 05/2024 - 01/2022
2	Chronic Renal Insufficiency 01/2024 - 04/2019
2	Postthrombotic Syndrome 07/2022 - 05/2018
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2021 - 07/2021
2	Diabetes Mellitus 01/2021 - 08/2016
2	Heart Failure 01/2021 - 04/2015
2	Vomiting 01/2019 - 01/2018
2	Frailty 10/2018 - 01/2018
2	Fibrosis (Cirrhosis) 01/2018 - 02/2014
1	Neurologic Manifestations (Neurological Manifestations) 05/2024
1	Rare Diseases (Rare Disease) 05/2024
1	Disease Progression 01/2024
1	Thrombophilia 10/2023
1	Sepsis (Septicemia) 10/2023
1	Premature Birth (Birth, Premature) 01/2022
1	Birth Weight (Birth Weights) 01/2022
1	Thrombotic Microangiopathies 08/2021
1	Infections 07/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Obesity 01/2021

Drug/Important Bio-Agent (IBA)

71	AnticoagulantsIBA 01/2024 - 01/2013
61	RivaroxabanIBA 02/2024 - 01/2013
31	Vitamin K FDA Link 01/2024 - 11/2013
22	N(4)-oleylcytosine arabinosideIBA 02/2024 - 01/2012
18	Factor Xa InhibitorsIBA 05/2024 - 11/2015
16	Warfarin (Coumadin)FDA LinkGeneric 10/2023 - 10/2014
13	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 12/2012
12	edoxabanIBA 10/2023 - 11/2015
11	Heparin (Liquaemin)FDA LinkGeneric 04/2024 - 01/2014
10	apixabanIBA 10/2023 - 01/2012
10	Enoxaparin (Lovenox)FDA LinkGeneric 01/2023 - 01/2014
9	PRT064445IBA 05/2024 - 01/2016
9	spermatogenesis associated factor (SPAF)IBA 02/2024 - 04/2015
7	Fondaparinux (Arixtra)FDA Link 10/2019 - 10/2011
5	Hemostatics (Antihemorrhagics)IBA 05/2024 - 01/2019
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2024 - 08/2016
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2021 - 08/2015
4	Factor Xa (Coagulation Factor Xa)IBA 01/2024 - 01/2016
4	fibrin fragment D (D-dimer)IBA 11/2023 - 04/2014
4	Prothrombin (Factor II)IBA 10/2023 - 08/2014
4	Dabigatran FDA Link 01/2018 - 10/2011
3	A-factor (Streptomyces)IBA 10/2023 - 01/2016
3	AntidotesIBA 10/2023 - 01/2022
3	prothrombin complex concentrates (PPSB)IBA 01/2022 - 01/2020
2	argatroban (MPQA)FDA Link 10/2023 - 11/2017
2	Blood Coagulation Factors (Coagulation Factor)IBA 10/2023 - 12/2017
2	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2022 - 01/2014
2	Dalteparin (Dalteparin Sodium)FDA Link 05/2022 - 08/2018
2	VaccinesIBA 08/2021 - 07/2021
2	Tenecteplase FDA Link 03/2017 - 04/2014
2	tetraethylpyrazine (TEP)IBA 01/2017 - 12/2012
2	Hormones (Hormone)IBA 10/2016 - 03/2016
1	eculizumab FDA Link 05/2024
1	AntithrombinsIBA 10/2023
1	ecarinIBA 10/2023
1	Factor IIaIBA 10/2023
1	1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)IBA 07/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Phenprocoumon (Liquamar)FDA Link 11/2022
1	COVID-19 VaccinesIBA 08/2021
1	Inosine Triphosphate (ITP)IBA 07/2021
1	Messenger RNA (mRNA)IBA 07/2021
1	CreatinineIBA 01/2021

Therapy/Procedure

56	Therapeutics 05/2024 - 04/2010
4	Secondary Prevention 11/2023 - 01/2018
4	Catheters 12/2021 - 01/2014
2	Aftercare (After-Treatment) 01/2021 - 01/2021
2	Anticoagulation Reversal 01/2021 - 01/2019
2	Bariatric Surgery 01/2021 - 11/2013
2	Surgical Amputation (Amputations) 10/2020 - 11/2017
2	Length of Stay 12/2017 - 01/2013
2	Orthopedic Procedures 01/2017 - 01/2012
2	Blood Transfusion (Blood Transfusions) 08/2016 - 02/2015
2	Thrombolytic Therapy 02/2016 - 04/2014
1	Percutaneous Coronary Intervention 10/2023
1	Free Tissue Flaps 07/2022
1	Palliative Care (Palliative Therapy) 05/2022
1	Drug Tapering 07/2021
1	Oral Administration 02/2021